iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$10.02 USD
+0.34 (3.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $10.03 +0.01 (0.10%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-1.18 | 0.00% |
Earnings Summary
For their last quarter, iTeos Therapeutics (ITOS) reported earnings of -$0.18 per share, beating the Zacks Consensus Estimate of $-1.04 per share. This reflects a positive earnings surprise of 82.69%. Look out for ITOS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$1.18 per share, reflecting a year-over-year decrease of 31.11%.
Earnings History
Price & Consensus
Zacks News for ITOS
Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?
ITOS: What are Zacks experts saying now?
Zacks Private Portfolio Services